Osteoporosis: Evolution in the Understanding of Metabolic Bone Disease

References

• Albright F, Ellsworth R: Uncharted Seas. Portland: JBK Publishing, Inc., 1990.
   Google Scholar
• LeBoff ML, Shoback D, Brown EM, Thatcher J, Lembruno R, Beaudoine D, Henry M, Wilson R, Pallotta J, Marynick SP, Stock J, Leight G: Regulation of parathyroid hormone release and cytosolic calcium by extracellular calcium in dispersed and cultured bovine and pathological human parathyroid cells. J Clin Invest 1985; 75: 49–57.
   PubMed Web of Science ®Google Scholar
• Albright F, Reifenstein EC: The Parathyroid Glands and Metabolic Bone Disease, Selected Studies. Baltimore: Williams & Wilkins, 1948.
   Google Scholar
• Recker RR: Clinical review 41: current therapy for osteoporosis. J Clin Endocrinol Metab 1993; 76: 14–16.
   PubMed Web of Science ®Google Scholar
• Recker RR, Davies KM, Hinders SM, Heaney RP, Stegman MR, Kimmel DB: Bone gain in young adult women. JAMA 1992; 268: 2403–2408.
   PubMed Web of Science ®Google Scholar
• Heaney RP: Calcium intake requirement and bone mass in the elderly. J Lab Clin Med 1982; 100: 309–312.
   PubMed Web of Science ®Google Scholar
• Hough S, Teitelbaum SL, Bergfeld MA, Avioli LV: Isolated skeletal involvement in Cushing's syndrome: response to therapy. J Clin Endocrinol Metab 1981; 52: 1033–1038.
   Web of Science ®Google Scholar
• Diamond T, Vine J, Smart R, Butler P: Thyrotoxic bone disease in women: a potentially reversible disorder. Ann Intern Med 1994; 120: 8–11.
   PubMed Web of Science ®Google Scholar
• Fallon MD, Perry HM III, Bergfeld M, Droke D, Teitelbaum SL, Avioli LV: Exogenous hyperthyroidism with osteoporosis. Arch Intern Med 1983; 143: 442–444.
   PubMedGoogle Scholar
• Ettinger B: Prevention of osteoporosis: treatment of estradiol deficiency. Obstet Gynecol 1988; 72: S12–S17.
   Web of Science ®Google Scholar
• Weiss NS, Ure CL, Ballard JH, Williams AR, Daling JR: Decreased risk of fracture of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med 1980; 303: 1195–1198.
   PubMed Web of Science ®Google Scholar
• Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM: Risk factors for hip fracture in white women: the study of Osteoporotic Fractures Research Group. N Engl J Med 1995; 332: 767–773.
   PubMed Web of Science ®Google Scholar
• Jensen J, Christiansen C, R⊘dbro P: Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause. N Engl J Med 1985; 313: 973–975.
   PubMed Web of Science ®Google Scholar
• Frame B, Parfitt AM: Osteomalacia: current concepts. Ann Intern Med 1978; 89: 966–982.
   PubMed Web of Science ®Google Scholar
• Mazess RB, Whedon GD: Immobilization and bone. Calcif Tissue Int 1983; 35: 265–267.
   PubMed Web of Science ®Google Scholar
• Christiansen CK, Lund B, Lund BJ, S⊘rensen OH, Nielsen HE, Mosekilde L: Reduced 1,25-dihydroxyvitamin D and 24,25-dihydroxyvitamin D in epileptic patients receiving chronic combined anticonvulsant therapy. Metabolic Bone Disease and Related Research 1981; 3: 17–22.
   Google Scholar
• Albright F, Aub JB, Bauer W: Hyperparathyroidism. JAMA 1934; 102: 1276–1287.
   Google Scholar
• Francis RM, Peacock M, Aaron JE, Selby PL, Taylor GA, Thompson J, Marshall DH, Horsman A: Osteoporosis in hypogonadal men: role of decreased plasma 1,25-dihydroxyvitamin D, calcium malabsorption, and low bone formation. Bone 1986; 7: 261–268.
   PubMed Web of Science ®Google Scholar
• Wolbach SB: The pathologic changes resulting from vitamin deficiency. JAMA 1937; 108: 7–13.
   Google Scholar
• Whyte MP, Walkenhorst DA, Fedde KN, Henthorn PS, Hill CS: Hypophosphatasia: levels of bone alkaline phosphatase immunoreactivity in serum reflect disease severity. J Clin Endocrinol Metab 1996; 81: 2142–2148.
   Web of Science ®Google Scholar
• Bricaire H, Joly J: Les hyperthyroïdes sans tachycardie. Presse Med 1965; 73: 557–559.
   Google Scholar
• Garton MJ, Reid DM: Bone mineral density of the hip and of the anteroposterior and lateral dimensions of the spine in men with rheumatoid arthritis: effects of low-dose corticosteroids. Arthritis Rheum 1993; 36: 222–228.
   PubMed Web of Science ®Google Scholar
• Bikle DD, Genant HK, Cann C, Recker RR, Halloran BP, Strewler GJ: Bone disease in alcohol abuse. Ann Intern Med 1985; 103: 42–48.
   PubMed Web of Science ®Google Scholar
• Epstein O, Kato Y, Dick R, Sherlock S: Vitamin D, hydroxyapatite, and calcium gluconate in treatment of cortical bone thinning in postmenopausal women with primary biliary cirrhosis. Am J Clin Nutr 1982; 36: 426–430.
   PubMed Web of Science ®Google Scholar
• Moore WT, Simon J, Taylor T: Diseases of bone. In Moore WT, Eastman RC, eds: Diagnostic Endocrinology, 2nd ed. St. Louis: Mosby-Year Book, Inc., 1996: 373–409.
   Google Scholar
• Marynick SP: Competitive-binding assays in clinical endocrinology. In Moore WT, Eastman RC, eds: Diagnostic Endocrinology, 2nd ed. St. Louis: Mosby-Year Book, Inc., 1996: 15–33.
   Google Scholar
• Mather HG: Hyperparathyroidism with normal serum calcium. BMJ 1953; 2: 424–425.
   PubMed Web of Science ®Google Scholar
• Whyte MP: Hypophosphatasia. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds: The Metabolic and Molecular Basis of Inherited Disease, 7th ed. New York: McGraw-Hill, 1995: 4095–4112.
   Google Scholar
• Riggs BL, Melton LJ III: Clinical review 8: clinical heterogeneity of involutional osteoporosis: implications for preventive therapy. J Clin Endocrinol Metab 1989; 70: 1229–1232.
   Web of Science ®Google Scholar
• Aloia JF, Vaswani A, Yeh JK, Ross PL, Flaster E, Dilmanian FA: Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss. Ann Intern Med 1994; 120: 97–103.
   PubMed Web of Science ®Google Scholar
• Mizuno K: Treatment of osteoporosis with special reference to the coexistence of osteoporosis and osteomalacia. Endocrinologia Japonica 1979; 26: S43–S56.
   Google Scholar